Whole soy, but not purified daidzein, had a favorable effect on improvement of cardiovascular risks: A 6‐month randomized, double‐blind, and placebo‐controlled trial in equol‐producing postmenopausal women

SCOPE: Equol is produced by the intestinal bacteria from isoflavone daidzein. Studies have reported the health benefits of soy can only present or more pronounced in equol producers. This 6‐month randomized controlled trial examined the effect of whole soy (soy flour) and purified daidzein on cardio...

Ausführliche Beschreibung